GSEA analysis demonstrates a positive correlation between high PCK2 expression and the gene set of the mesenchymal subtype signature in glioma patients, while a negative correlation with the proneural signature (Fig. 2H-I). The gene discussed is PCK2; the disease is central nervous system cancer.